These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 26344877)
1. The CHCHD10 P34S variant is not associated with ALS in a UK cohort of familial and sporadic patients. Wong CH; Topp S; Gkazi AS; Troakes C; Miller JW; de Majo M; Kirby J; Shaw PJ; Morrison KE; de Belleroche J; Vance CA; Al-Chalabi A; Al-Sarraj S; Shaw CE; Smith BN Neurobiol Aging; 2015 Oct; 36(10):2908.e17-8. PubMed ID: 26344877 [TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of CHCHD10 in French familial amyotrophic lateral sclerosis patients. Teyssou E; Chartier L; Albert M; Bouscary A; Antoine JC; Camdessanché JP; Rotolo F; Couratier P; Salachas F; Seilhean D; Millecamps S Neurobiol Aging; 2016 Jun; 42():218.e1-3. PubMed ID: 27095681 [TBL] [Abstract][Full Text] [Related]
3. CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients. Chiò A; Mora G; Sabatelli M; Caponnetto C; Traynor BJ; Johnson JO; Nalls MA; Calvo A; Moglia C; Borghero G; Monsurrò MR; La Bella V; Volanti P; Simone I; Salvi F; Logullo FO; Nilo R; Battistini S; Mandrioli J; Tanel R; Murru MR; Mandich P; Zollino M; Conforti FL; ; Brunetti M; Barberis M; Restagno G; Penco S; Lunetta C Neurobiol Aging; 2015 Apr; 36(4):1767.e3-1767.e6. PubMed ID: 25726362 [TBL] [Abstract][Full Text] [Related]
4. Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice. McCann EP; Fifita JA; Grima N; Galper J; Mehta P; Freckleton SE; Zhang KY; Henden L; Hogan AL; Chan Moi Fat S; Wu SS; Jagaraj CJ; Berning BA; Williams KL; Twine NA; Bauer D; Piguet O; Hodges J; Kwok JBJ; Halliday GM; Kiernan MC; Atkin J; Rowe DB; Nicholson GA; Walker AK; Blair IP; Yang S J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):162-171. PubMed ID: 31690696 [TBL] [Abstract][Full Text] [Related]
5. Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients. Chaussenot A; Le Ber I; Ait-El-Mkadem S; Camuzat A; de Septenville A; Bannwarth S; Genin EC; Serre V; Augé G; ; Brice A; Pouget J; Paquis-Flucklinger V Neurobiol Aging; 2014 Dec; 35(12):2884.e1-2884.e4. PubMed ID: 25155093 [TBL] [Abstract][Full Text] [Related]
6. Mutation Screening of the CHCHD10 Gene in Chinese Patients with Amyotrophic Lateral Sclerosis. Zhou Q; Chen Y; Wei Q; Cao B; Wu Y; Zhao B; Ou R; Yang J; Chen X; Hadano S; Shang HF Mol Neurobiol; 2017 Jul; 54(5):3189-3194. PubMed ID: 27056076 [TBL] [Abstract][Full Text] [Related]
7. CHCHD10 mutations in patients with amyotrophic lateral sclerosis in Mainland China. Shen S; He J; Tang L; Zhang N; Fan D Neurobiol Aging; 2017 Jun; 54():214.e7-214.e10. PubMed ID: 28318595 [TBL] [Abstract][Full Text] [Related]
8. Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients. Perrone F; Nguyen HP; Van Mossevelde S; Moisse M; Sieben A; Santens P; De Bleecker J; Vandenbulcke M; Engelborghs S; Baets J; Cras P; Vandenberghe R; De Jonghe P; De Deyn PP; Martin JJ; Van Damme P; Van Broeckhoven C; van der Zee J; Neurobiol Aging; 2017 Mar; 51():177.e9-177.e16. PubMed ID: 28069311 [TBL] [Abstract][Full Text] [Related]
9. CHCHD10 variants in amyotrophic lateral sclerosis: Where is the evidence? Project MinE ALS Sequencing Consortium Ann Neurol; 2018 Jul; 84(1):110-116. PubMed ID: 30014597 [TBL] [Abstract][Full Text] [Related]
10. Screening for CHCHD10 mutations in a large cohort of sporadic ALS patients: no evidence for pathogenicity of the p.P34S variant. Marroquin N; Stranz S; Müller K; Wieland T; Ruf WP; Brockmann SJ; Danzer KM; Borck G; Hübers A; Weydt P; Meitinger T; Strom TM; Rosenbohm A; Ludolph AC; Weishaupt JH Brain; 2016 Feb; 139(Pt 2):e8. PubMed ID: 26362909 [No Abstract] [Full Text] [Related]
11. CHCHD10 is not a frequent causative gene in Chinese ALS patients. Li XL; Shu S; Li XG; Liu Q; Liu F; Cui B; Liu MS; Peng B; Cui LY; Zhang X Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(5-6):458-60. PubMed ID: 27077676 [TBL] [Abstract][Full Text] [Related]
12. Identification of CHCHD10 Mutation in Chinese Patients with Alzheimer Disease. Xiao T; Jiao B; Zhang W; Pan C; Wei J; Liu X; Zhou Y; Zhou L; Tang B; Shen L Mol Neurobiol; 2017 Sep; 54(7):5243-5247. PubMed ID: 27578015 [TBL] [Abstract][Full Text] [Related]
13. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Bannwarth S; Ait-El-Mkadem S; Chaussenot A; Genin EC; Lacas-Gervais S; Fragaki K; Berg-Alonso L; Kageyama Y; Serre V; Moore DG; Verschueren A; Rouzier C; Le Ber I; Augé G; Cochaud C; Lespinasse F; N'Guyen K; de Septenville A; Brice A; Yu-Wai-Man P; Sesaki H; Pouget J; Paquis-Flucklinger V Brain; 2014 Aug; 137(Pt 8):2329-45. PubMed ID: 24934289 [TBL] [Abstract][Full Text] [Related]
14. CHCHD10 Pro34Ser is not a highly penetrant pathogenic variant for amyotrophic lateral sclerosis and frontotemporal dementia. Abdelkarim S; Morgan S; Plagnol V; Lu CH; Adamson G; Howard R; Malaspina A; Orrell R; Sharma N; Sidle K; Clarke J; Fox NC; Rossor MN; Warren JD; Clark CN; Rohrer JD; Fisher EM; Mead S; Pittman A; Fratta P Brain; 2016 Feb; 139(Pt 2):e9. PubMed ID: 26362910 [No Abstract] [Full Text] [Related]
15. Meta-analysis of the association between CHCHD10 Pro34Ser variant and the risk of amyotrophic lateral sclerosis. Yang B; Yang C; Ren J; Zhong C; Liu K; Zhao L; Li L; Wang H; Zhu M; Lin Z Neurol Sci; 2021 Feb; 42(2):625-631. PubMed ID: 32651855 [TBL] [Abstract][Full Text] [Related]
16. Loss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS. Straub IR; Janer A; Weraarpachai W; Zinman L; Robertson J; Rogaeva E; Shoubridge EA Hum Mol Genet; 2018 Jan; 27(1):178-189. PubMed ID: 29121267 [TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients. Millecamps S; De Septenville A; Teyssou E; Daniau M; Camuzat A; Albert M; LeGuern E; Galimberti D; ; Brice A; Marie Y; Le Ber I Neurobiol Aging; 2014 Dec; 35(12):2882.e13-2882.e15. PubMed ID: 25158920 [TBL] [Abstract][Full Text] [Related]
18. VCP mutations are not a major cause of familial amyotrophic lateral sclerosis in the UK. Kwok CT; Wang HY; Morris AG; Smith B; Shaw C; de Belleroche J J Neurol Sci; 2015 Feb; 349(1-2):209-13. PubMed ID: 25618255 [TBL] [Abstract][Full Text] [Related]
19. A novel CHCHD10 mutation implicates a Mia40-dependent mitochondrial import deficit in ALS. Lehmer C; Schludi MH; Ransom L; Greiling J; Junghänel M; Exner N; Riemenschneider H; van der Zee J; Van Broeckhoven C; Weydt P; Heneka MT; Edbauer D EMBO Mol Med; 2018 Jun; 10(6):. PubMed ID: 29789341 [No Abstract] [Full Text] [Related]
20. Screening for OPTN mutations in a cohort of British amyotrophic lateral sclerosis patients. Johnson L; Miller JW; Gkazi AS; Vance C; Topp SD; Newhouse SJ; Al-Chalabi A; Smith BN; Shaw CE Neurobiol Aging; 2012 Dec; 33(12):2948.e15-7. PubMed ID: 22892313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]